[1]Patent:WO2010/91310,2010,A1.Locationinpatent:Page/Pagecolumn164
[2]Patent:EP3401309,2018,A1.Locationinpatent:Paragraph0896
[3]Patent:EP3712129,2020,A1.Locationinpatent:Paragraph1084
134168-97-1
1003-99-2
1257535-28-6
1257535-06-0
1269232-99-6
2924-09-6
1403483-71-5 | 4-(4-Bromo-2-methoxyphenoxy)-1-methylpiperidine | AA009X0Q | MFCD22549306
1217464-96-4 | (R)-1-(5-Chloro-2-fluorophenyl)ethanamine hydrochloride | AA009XCF | MFCD16294082
1311140-98-3 | Myo-Inositol 1,2,3-Trisphosphate | AA009XP8
1248738-39-7 | 1-bromo-3-((2,2,2-trifluoroethoxy)methyl)benzene | AA009YEB | MFCD14686963
1353498-59-5 | Ethyl pyrazolo[1,5-a]pyrimidine-2-carboxylate | AA009YOQ | MFCD21090726
1262897-74-4 | GEMCITABINE-13C,15N2 HYDROCHLORIDE | AA009Z2B | MFCD09840661
1269036-30-7 | N-[1-(2-METHOXYPHENYL)ETHYL]-N-METHYLAMINE HYDROCHLORIDE | AA009ZR8 | MFCD18483380
1428532-93-7 | 8-Chloro-6-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one | AA00A02T | MFCD12406875
1274859-33-4 | VU 0360223 | AA00A0KV | MFCD20926362
1351373-47-1 | Bis-propargyl-peg10 | AA00A15D | MFCD28976686